Citation: Qiyao Zhang, Yuting Li, Qishun Jin, Zhengwei Liu, Hongsong Chen, Jingqi Huang, Taoyi Liu, Xiaojuan Liu, Zhenghuai Tan, Shuheng Huang, Wu Dong, Zhipei Sang. Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer’s disease[J]. Chinese Chemical Letters, ;2026, 37(1): 110964. doi: 10.1016/j.cclet.2025.110964 shu

Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer’s disease

Qiyao Zhang ^{a, b, 1} ,
Yuting Li ^{a, c, 1} ,
Qishun Jin ^{a, 1} ,
Zhengwei Liu ^{a, d, 1} ,
Hongsong Chen ^e ,
Jingqi Huang ^a ,
Taoyi Liu ^a ,
Xiaojuan Liu ^a ,
Zhenghuai Tan ^f ,
Shuheng Huang ^{a, *,} ,
Wu Dong ^{e, *,} ,
Zhipei Sang ^{a, *,}

a.
Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China
b.
School of Food Science and Engineering, Hainan University, Haikou 570228, China
c.
School of Life and Health Sciences, Hainan University, Haikou 570228, China
d.
College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China
e.
College of Animal Science and Technology, Inner Mongolia Minzu University, Tongliao 028000, China
f.
Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan Academy of Chinese Medicine Sciences, Chengdu 610041, China

shhuang@hainanu.edu.cn

dongwu@imun.edu.cn

sangzhipei@hainanu.edu.cn

Received Date: 9 December 2024
Revised Date: 14 February 2025
Accepted Date: 17 February 2025
Available Online: 17 February 2025

Figures(5)

Alzheimer’s disease (AD) is a common neurodegenerative disorder among the elderly population. There are currently no effective therapeutic drugs available, the multi-target-directed ligands (MTDLs) strategy has been considered as the promising approach. Given the structural diversity of natural products, Rivastigmine’s pharmacophore was integrated with diverse natural product scaffolds to construct a combinatorial compound library. This library was subsequently screened and optimized to identify a novel butyrylcholinesterase (BuChE) inhibitor, compound 3c. The results showed that compound 3c exhibited favorable BuChE inhibitory activity (half-maximal inhibitory concentration (IC₅₀) = 0.43 µmol/L), potential anti-inflammatory potency, good Aβ_1–42 aggregation inhibitory capacity and remarkable neuroprotective effects. The in vivo study exhibited that 3c significantly ameliorated AlCl₃-induced zebrafish AD model and scopolamine-induced memory impairment. Collectively, compound 3c was the artificial intelligence (AI)-driven promising multifunctional agent with BuChE inhibition for the treatment of AD.
- Alzheimer’s disease,
- AI-driven,
- Multifunctional agents,
- BuChE inhibitor,
- In vivo study
1. [1]
  R. Hodson, Nature 559 (2018) S1. doi: 10.1038/d41586-018-05717-6
2. [2]
  J.F. Zhang, Y.L. Zhang, J.X. Wang, et al., Signal Transduct. Target. Ther. 9 (2024) 211. doi: 10.1038/s41392-024-01911-3
3. [3]
  Q. Zheng, X. Wang, Protein Cell 16 (2025) 83–120. doi: 10.1093/procel/pwae026
4. [4]
  Z.P. Sang, K.R. Wang, J.H. Dong, et al., Eur. J. Med. Chem. 238 (2022) 114464. doi: 10.1016/j.ejmech.2022.114464
5. [5]
  J.B. Sun, H. Zhong, K. Wang, et al., Acta Pharm. Sin. B 11 (2021) 3417–3432. doi: 10.1016/j.apsb.2021.02.023
6. [6]
  D. Knez, D. Diez-Iriepa, M. Chioua, et al., Acta Pharm. Sin. B 13 (2023) 2152–2175. doi: 10.1016/j.apsb.2023.01.013
7. [7]
  E. Giacobini, A.C. Cuello, A. Fisher, Brain 145 (2022) 2250–2275. doi: 10.1093/brain/awac096
8. [8]
  S.S. Xing, Q. Li, B.C. Xiong, et al., Med. Res. Rev. 41 (2021) 858–901. doi: 10.1002/med.21745
9. [9]
  S. Darvesh, D.A. Hopkins, C. Geula, Nat. Rev. Neurosci. 4 (2003) 131–138. doi: 10.1038/nrn1035
10. [10]
  I. Manoharan, R. Boopathy, S. Darvesh, O. Lockridge, Clin. Chim. Acta 378 (2007) 128–135. doi: 10.1016/j.cca.2006.11.005
11. [11]
  G.A. Reid, S. Darvesh, Neuroscience 98 (2015) 424–435. doi: 10.1016/j.neuroscience.2015.04.039
12. [12]
  T. Maurice, M. Strehaiano, N. Siméon, et al., Behav. Brain Res. 296 (2016) 351–360. doi: 10.1016/j.bbr.2015.08.026
13. [13]
  L.L. Jing, W.X. Wei, B.R. Meng, et al., Bioorg. Chem. 134 (2023) 106465. doi: 10.1016/j.bioorg.2023.106465
14. [14]
  J. Moreira, M. Machado, M. Dias-Teixeira, et al., Acta Pharm. Sin. B 13 (2023) 3208–3237. doi: 10.1016/j.apsb.2023.06.009
15. [15]
  S.S. Panda, N. Jhanji, Curr. Med. Chem. 27 (2020) 5887–5917. doi: 10.2174/0929867326666190618113613
16. [16]
  K. Wojtunik-Kulesza, T. Oniszczuk, J. Mołdoch, et al., Int. J. Mol. Sci. 23 (2022) 1212. doi: 10.3390/ijms23031212
17. [17]
  X. Chen, J. Drew, W. Berney, W. Lei, Cells 10 (2021) 1309. doi: 10.3390/cells10061309
18. [18]
  A.K. Desai, G.T. Grossberg, Expert Rev. Neurother. 5 (2005) 563–580. doi: 10.1586/14737175.5.5.563
19. [19]
  H.H. Zhang, Y.Y. Wang, Y.Q. Wang, et al., Eur. J. Med. Chem. 240 (2022) 114606. doi: 10.1016/j.ejmech.2022.114606
20. [20]
  A. Matošević, A. Bosak, Arh. Hig. Rada Toksikol. 71 (2020) 285–299. doi: 10.2478/aiht-2020-71-3466
21. [21]
  M.T. Kabir, M.S. Uddin, M.M. Begum, et al., Curr. Pharm. Des. 25 (2019) 3519–3535. doi: 10.2174/1381612825666191008103141
22. [22]
  R. Gupta, D. Srivastava, M. Sahu, et al., Mol. Divers. 25 (2021) 1315–1360. doi: 10.1007/s11030-021-10217-3
23. [23]
  R.Y. Choi, A.S. Coyner, J. Kalpathy-Cramer, et al., Transl. Vis. Sci. Technol. 9 (2020) 14. doi: 10.1167/tvst.9.2.14
24. [24]
  K. Crampon, A. Giorkallos, M. Deldossi, et al., Drug Discov. Today 27 (2022) 151–164. doi: 10.1016/j.drudis.2021.09.007
25. [25]
  Z.P. Sang, P. Bai, Y.J. Ban, et al., Bioorg. Chem. 127 (2022) 106007. doi: 10.1016/j.bioorg.2022.106007
26. [26]
  X.N. Wu, Y.D. Huang, J.X. Li, et al., Acta Pharm. Sin. B 8 (2018) 615–628. doi: 10.1016/j.apsb.2017.12.007
27. [27]
  X.L. Deng, J. Xie, Y.Q. Li, et al., Chin. Chem. Lett. 27 (2016) 566–570. doi: 10.1016/j.cclet.2016.02.009
28. [28]
  Z.P. Sang, K.R. Wang, J. Shi, et al., Eur. J. Med. Chem. 187 (2020) 111958. doi: 10.1016/j.ejmech.2019.111958
29. [29]
  B. Zhen, X.Y. Suo, J. Dang, et al., Chin. Chem. Lett. 32 (2021) 2338–2341. doi: 10.1016/j.cclet.2020.10.027
30. [30]
  R. Chen, X. Li, H. Chen, et al., Eur. J. Med. Chem. 251 (2023) 115253. doi: 10.1016/j.ejmech.2023.115253
31. [31]
  P. Wang, Y. Wang, P. Li, et al., Chin. Chem. Lett. 34 (2023) 107691. doi: 10.1016/j.cclet.2022.07.034
32. [32]
  Z.P. Sang, K.R. Wang, P.F. Zhang, et al., Eur. J. Med. Chem. 180 (2019) 238–252. doi: 10.1016/j.ejmech.2019.07.021
33. [33]
  E.E. Patton, L.I. Zon, D.M. Langenau, Nat. Rev. Drug Discov. 20 (2021) 611–628. doi: 10.1038/s41573-021-00210-8
34. [34]
  H.S. Chen, J. Mi, S. Li, et al., J. Enzyme Inhib. Med. Chem. 38 (2023) 2169682. doi: 10.1080/14756366.2023.2169682
1. [1]
  Jiajie Gu , Jiaxiang Gu , Lei Yu . Selenium and Alzheimer's disease. Chinese Chemical Letters, 2025, 36(8): 110727-. doi: 10.1016/j.cclet.2024.110727
2. [2]
  Weiqun Li , Ming-Jie Dong , Haibing Dai , Shanming Lu , Ran Luo , Jiahui Cao , Fan Zhang , Lin Mei , Jianbo Yu . Application of mitochondrial miRNA-204 nanoprobes in Alzheimer's disease treatment by clearing reactive oxygen species-mediated autophagy. Chinese Chemical Letters, 2025, 36(8): 110614-. doi: 10.1016/j.cclet.2024.110614
3. [3]
  Xiaoxiao Wang , Bolun Wang , Fenfen Ji , Jie Yan , Jiacheng Fang , Doudou Zhang , Ji Xu , Jing Ji , Xinran Hao , Hemi Luan , Yanjun Hong , Shulan Qiu , Min Li , Zhu Yang , Wenlan Liu , Xiaodong Cai , Zongwei Cai . Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics. Chinese Chemical Letters, 2024, 35(11): 109653-. doi: 10.1016/j.cclet.2024.109653
4. [4]
  Tao Liu , Xuwei Han , Xueyi Sun , Weijie Zhang , Ke Gao , Runan Min , Yuting Tian , Caixia Yin . An activated fluorescent probe to monitor NO fluctuation in Parkinson’s disease. Chinese Chemical Letters, 2025, 36(3): 110170-. doi: 10.1016/j.cclet.2024.110170
5. [5]
  Yiwen Xu , Chaozheng He , Chenxu Zhao , Ling Fu . Single-atom Ti doping on S-vacancy two-dimensional CrS₂ as a catalyst for ammonia synthesis: A DFT study. Chinese Chemical Letters, 2025, 36(4): 109797-. doi: 10.1016/j.cclet.2024.109797
6. [6]
  Sajid Hussain , Omer M.A. Dagah , Essam A.M.S Obaid , Peng Jin , Ovas Ahmed Dar , Muhammd Irfan , Yiming Qi , Qinghua Wu , Ming Jin , Tengli Zhang , Lei Luo . Chitosan as oral absorption enhancer and inhibitor: A comprehensive review. Chinese Chemical Letters, 2026, 37(1): 111273-. doi: 10.1016/j.cclet.2025.111273
7. [7]
  Zihong Li , Jie Cheng , Ping Huang , Guoliang Wu , Weiying Lin . Activatable photoacoustic bioprobe for visual detection of aging in vivo. Chinese Chemical Letters, 2024, 35(4): 109153-. doi: 10.1016/j.cclet.2023.109153
8. [8]
  Shihong Wu , Ronghui Zhou , Hang Zhao , Peng Wu . Sonoafterglow luminescence for in vivo deep-tissue imaging. Chinese Chemical Letters, 2024, 35(10): 110026-. doi: 10.1016/j.cclet.2024.110026
9. [9]
  Gongcheng Ma , Qihang Ding , Yuding Zhang , Yue Wang , Jingjing Xiang , Mingle Li , Qi Zhao , Saipeng Huang , Ping Gong , Jong Seung Kim . Palladium-free chemoselective probe for in vivo fluorescence imaging of carbon monoxide. Chinese Chemical Letters, 2024, 35(9): 109293-. doi: 10.1016/j.cclet.2023.109293
10. [10]
  Qian Pang , Fangjun Huo , Yongkang Yue , Caixia Yin . ONOO⁻ and viscosity dual-response fluorescent probe for arthritis imaging in vivo. Chinese Chemical Letters, 2025, 36(9): 110713-. doi: 10.1016/j.cclet.2024.110713
11. [11]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
12. [12]
  Zikang Hu , Hengjie Zhang , Zhengqiu Li , Tianbao Zhao , Zhipeng Gu , Qijuan Yuan , Baoshu Chen . Multifunctional photothermal hydrogels: Design principles, various functions, and promising biological applications. Chinese Chemical Letters, 2024, 35(10): 109527-. doi: 10.1016/j.cclet.2024.109527
13. [13]
  Mengya Ge , Zijie Zhou , Huaiyang Zhu , Ying Wang , Chao Wang , Chao Lai , Qinghong Wang . Multifunctional gel electrolytes for high-performance zinc metal batteries. Chinese Chemical Letters, 2025, 36(7): 110121-. doi: 10.1016/j.cclet.2024.110121
14. [14]
  Li Qin , Wenjing Wei , Keqing Wang , Xianbao Shi , Guixia Ling , Peng Zhang . Ultrasound-responsive heterojunction sonosensitizers for multifunctional synergistic sonodynamic therapy. Chinese Chemical Letters, 2025, 36(7): 110777-. doi: 10.1016/j.cclet.2024.110777
15. [15]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
16. [16]
  Zhikang Wu , Guoyong Dai , Qi Li , Zheyu Wei , Shi Ru , Jianda Li , Hongli Jia , Dejin Zang , Mirjana Čolović , Yongge Wei . POV-based molecular catalysts for highly efficient esterification of alcohols with aldehydes as acylating agents. Chinese Chemical Letters, 2024, 35(8): 109061-. doi: 10.1016/j.cclet.2023.109061
17. [17]
  Lan Yang , Yu Li , Mou Jiang , Rui Zhou , Hengjiang Cong , Minghui Yang , Lei Zhang , Shenhui Li , Yunhuang Yang , Maili Liu , Xin Zhou , Zhong-Xing Jiang , Shizhen Chen . Fluorinated [2]rotaxanes as sensitive ¹⁹F MRI agents: Threading for higher sensitivity. Chinese Chemical Letters, 2024, 35(10): 109512-. doi: 10.1016/j.cclet.2024.109512
18. [18]
  Mianling Yang , Meehyein Kim , Peng Zhan . Modular miniaturized synthesis and in situ biological evaluation facilitate rapid discovery of potent MraY inhibitors as antibacterial agents. Chinese Chemical Letters, 2025, 36(2): 110455-. doi: 10.1016/j.cclet.2024.110455
19. [19]
  Rui WU , Yankun ZHANG , Jiufu LU , Pengfei ZHANG , Yang WANG . Research process on radioactive ¹⁸F-labelled chemical agents as positron emission tomography imaging probes for tumour detection. Chinese Journal of Inorganic Chemistry, 2025, 41(9): 1702-1718. doi: 10.11862/CJIC.20240387
20. [20]
  Fangwen Peng , Zhen Luo , Yingjin Ma , Haibo Ma . Theoretical study of aromaticity reversal in dimethyldihydropyrene derivatives. Chinese Journal of Structural Chemistry, 2024, 43(5): 100273-100273. doi: 10.1016/j.cjsc.2024.100273

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(8)
HTML views(1)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142